tiprankstipranks
Trending News
More News >
Diamines & Chemicals Ltd. (IN:DIAMINESQ)
:DIAMINESQ
India Market

Diamines & Chemicals Ltd. (DIAMINESQ) AI Stock Analysis

Compare
1 Followers

Top Page

IN:DIAMINESQ

Diamines & Chemicals Ltd.

(DIAMINESQ)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
₹253.00
▼(-3.64% Downside)
The score is primarily held back by weak FY2025 financial performance—sharp margin compression and negative operating/free cash flow—despite a very conservative, low-debt balance sheet. Technicals also remain bearish (below key moving averages with negative MACD), and valuation support is limited given a negative P/E and a very low dividend yield.

Diamines & Chemicals Ltd. (DIAMINESQ) vs. iShares MSCI India ETF (INDA)

Diamines & Chemicals Ltd. Business Overview & Revenue Model

Company DescriptionDiamines and Chemicals Limited manufactures and sells organic chemical compounds in India. The company's products include piperazine anhydrous, ethylenediamine, diethylenetriamine, aminoethylpiperazine, triethylenetetramine, tetraethylenepentamine, polyethylene polyamine-mix, monoethanol amine, triethylenediamine, diaminopropane, dipropylene triamine, diacetyl ethylenediamine, tetracetyl ethylenediamine, tetra methyl ethylenediamine, and amine mixture, as well as piperazine derivatives. It exports its chemical products. The company was incorporated in 1976 and is based in Vadodara, India.
How the Company Makes Money

Diamines & Chemicals Ltd. Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue668.87M714.72M1.03B1.10B658.90M626.92M
Gross Profit365.24M353.88M444.26M737.89M375.84M400.07M
EBITDA72.45M86.12M251.30M581.54M237.95M275.95M
Net Income16.65M27.31M154.71M419.04M167.14M209.95M
Balance Sheet
Total Assets0.001.78B1.63B1.51B1.11B947.79M
Cash, Cash Equivalents and Short-Term Investments394.24M413.96M362.95M248.05M390.90M311.12M
Total Debt0.00251.00K0.000.000.003.02M
Total Liabilities-1.61B168.31M145.62M165.51M103.56M97.92M
Stockholders Equity1.61B1.61B1.48B1.35B1.00B849.87M
Cash Flow
Free Cash Flow0.00-90.37M132.88M-70.06M123.03M40.55M
Operating Cash Flow0.00-50.22M218.96M162.85M272.74M153.66M
Investing Cash Flow0.00146.54M-188.33M-86.63M-214.91M-149.27M
Financing Cash Flow0.0097.47M-31.29M-60.15M-52.80M-36.86M

Diamines & Chemicals Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
₹9.08B12.900.38%13.01%32.44%
63
Neutral
₹8.20B17.900.38%12.35%6.79%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹5.96B21.400.97%40.79%109.95%
53
Neutral
₹4.03B17.2639.31%
45
Neutral
₹3.15B-4.83-1.30%-27.85%
43
Neutral
₹2.53B-51.130.38%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DIAMINESQ
Diamines & Chemicals Ltd.
258.55
-200.74
-43.71%
IN:DMCC
DMCC Speciality Chemicals Limited
239.00
-86.51
-26.58%
IN:INDOAMIN
Indo Amines Limited
125.10
-23.18
-15.63%
IN:INDOBORAX
Indo Borax & Chemicals Limited
255.40
98.41
62.69%
IN:KANORICHEM
Kanoria Chemicals & Industries Ltd
72.00
-32.60
-31.17%
IN:LORDSCHLO
Lords Chloro Alkali Limited
160.25
-29.40
-15.50%

Diamines & Chemicals Ltd. Corporate Events

Diamines & Chemicals Ltd. Opens Special Window for Physical Share Transfers
Nov 20, 2025

Diamines & Chemicals Ltd. has announced the opening of a special window for shareholders to re-lodge transfer requests for physical shares. This initiative, communicated through newspaper notices, aligns with SEBI regulations and aims to facilitate the process for shareholders holding physical share certificates. This move is expected to streamline share transfer processes and ensure compliance with regulatory requirements, potentially impacting the company’s shareholder engagement and operational efficiency.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026